- Home
- SGRP vs DYAI Comparison
SGRP vs DYAI Comparison
Compare SGRP & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- DYAI
- Stock Information
- Founded
- SGRP 1967
- DYAI 1979
- Country
- SGRP United States
- DYAI United States
- Employees
- SGRP N/A
- DYAI N/A
- Industry
- SGRP Business Services
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SGRP Consumer Discretionary
- DYAI Health Care
- Exchange
- SGRP Nasdaq
- DYAI Nasdaq
- Market Cap
- SGRP 27.3M
- DYAI 30.2M
- IPO Year
- SGRP 1996
- DYAI 2004
- Fundamental
- Price
- SGRP $1.05
- DYAI $0.97
- Analyst Decision
- SGRP
- DYAI Strong Buy
- Analyst Count
- SGRP 0
- DYAI 2
- Target Price
- SGRP N/A
- DYAI $4.50
- AVG Volume (30 Days)
- SGRP 51.8K
- DYAI 80.8K
- Earning Date
- SGRP 11-14-2025
- DYAI 11-12-2025
- Dividend Yield
- SGRP N/A
- DYAI N/A
- EPS Growth
- SGRP N/A
- DYAI N/A
- EPS
- SGRP N/A
- DYAI N/A
- Revenue
- SGRP $143,501,000.00
- DYAI $4,135,078.00
- Revenue This Year
- SGRP $7.22
- DYAI $18.18
- Revenue Next Year
- SGRP N/A
- DYAI $87.65
- P/E Ratio
- SGRP N/A
- DYAI N/A
- Revenue Growth
- SGRP N/A
- DYAI 129.20
- 52 Week Low
- SGRP $0.91
- DYAI $0.71
- 52 Week High
- SGRP $2.46
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- SGRP 46.12
- DYAI 37.18
- Support Level
- SGRP $1.03
- DYAI $1.07
- Resistance Level
- SGRP $1.15
- DYAI $1.21
- Average True Range (ATR)
- SGRP 0.04
- DYAI 0.11
- MACD
- SGRP 0.00
- DYAI -0.02
- Stochastic Oscillator
- SGRP 21.42
- DYAI 9.22
About SGRP SPAR Group Inc.
SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.